JBIO Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Zacks Investment Research

What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock

5 days ago - By: Zacks Investment Research

Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know

6 days ago - By: Benzinga - Mentions: TERN SGML COCO IVVD ...

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday

10 days ago - By: Jade Biosciences

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

2 months ago - By: Jade Biosciences

Jade Biosciences Announces $135 Million Private Placement

3 months ago - By: Jade Biosciences

Jade Biosciences to Participate in Upcoming Conferences

10 days ago - By: Jade Biosciences

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

15 days ago - By: Jade Biosciences

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

15 days ago - By: Jade Biosciences

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

3 months ago - By: The Motley Fool

Jade Biosciences Posts Wider Loss in Q2

5 months ago - By: Jade Biosciences

Jade Biosciences to Participate in Two Upcoming Investor Conferences

5 months ago - By: Jade Biosciences

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

20 days ago - By: Jade Biosciences

Jade Biosciences to Participate in Upcoming Conferences

20 days ago - By: Jade Biosciences

Jade Biosciences to Participate in Upcoming Conferences

a month ago - By: Jade Biosciences

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

a month ago - By: Jade Biosciences

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

2 months ago - By: Jade Biosciences

Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases

2 months ago - By: Jade Biosciences

Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases

2 months ago - By: Jade Biosciences

Jade Biosciences Announces $135 Million Private Placement

2 months ago - By: Benzinga - Mentions: BOLT TTNP APDN KMDA ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

3 months ago - By: Jade Biosciences

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy

3 months ago - By: Jade Biosciences

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy

3 months ago - By: Jade Biosciences

Jade Biosciences to Participate in Upcoming Conferences

3 months ago - By: Jade Biosciences

Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Jade Biosciences

Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update

5 months ago - By: Jade Biosciences

Jade Biosciences to Participate in Two Upcoming Investor Conferences

5 months ago - By: Jade Biosciences

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

5 months ago - By: Yahoo Finance

2 Small-Cap Stocks Under $10 to Buy With Big Potential

6 months ago - By: Jade Biosciences

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

6 months ago - By: Jade Biosciences

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

6 months ago - By: Jade Biosciences

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress

6 months ago - By: Jade Biosciences

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress

6 months ago - By: Jade Biosciences

JADE BIOSCIENCES INC (JBIO) Stock News

JBIO Latest News, Press Relases and Analysis

What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock

Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Jade Biosciences Announces $135 Million Private Placement

Jade Biosciences to Participate in Upcoming Conferences

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

Jade Biosciences Posts Wider Loss in Q2

Jade Biosciences to Participate in Two Upcoming Investor Conferences

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

Jade Biosciences to Participate in Upcoming Conferences

Jade Biosciences to Participate in Upcoming Conferences

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases

Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases

Jade Biosciences Announces $135 Million Private Placement

12 Health Care Stocks Moving In Wednesday's After-Market Session

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy

Jade Biosciences to Participate in Upcoming Conferences

Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jade Biosciences to Participate in Two Upcoming Investor Conferences

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

2 Small-Cap Stocks Under $10 to Buy With Big Potential

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress

Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update